Some common diagnostic and prognostic biomarkers such as human epidermal growth factor receptor (HER2), oestrogen receptor (ER) and progesterone receptor (PR) can guide therapy in breast cancer.9 This evidence concerns the gene ERBB2 and breast carcinoma.